Reset filter
Mots-clés
On-Study Form ×
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
    1. 7.1. Anesthésie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Gériatrie
    1. 7.5. Gynécologie/obstétrique
    1. 7.6. Médecine interne
      1. Hématologie
      1. Infectiologie
      1. Cardiologie/angiologie
      1. Pneumologie
      1. Gastroentérologie
      1. Néphrologie
      1. Endocrinologie/métabolisme
      1. Rhumatologie
    1. 7.7. Neurologie
    1. 7.8. Ophtalmologie
    1. 7.9. Médecine palliative
    1. 7.10. Pathologie/médécine légale
    1. 7.11. Pédiatrie
    1. 7.12. Psychiatrie/psychosomatique
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Chirurgie générale/viscérale
      1. Neurochirurgie
      1. Chirurgie plastique
      1. Chirurgie cardiaque/thoracique
      1. Chirurgie traumatologique/orthopédie
      1. Chirurgie vasculaire
    1. 7.15. Urologie
    1. 7.16. Médecine dentaire/MKG
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

55 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

On-Study - Metastatic Brain Cancer - On-Study Form - 2287553v3.0 - Metastatic Brain Cancer - On-Study Form

- 09/01/2015 - 1 Formulaire, 10 Groupes Item, 64 Eléments de données, 1 Langue
Groupes Item: CRF Header, Brain: Form Administration, Non-CNS: Initial Disease Description, Brain: Current Disease Description, Brain: Concomitant Medications, Metastatic Brain: Prior Health History, Metastatic Brain: Prior Treatment, Brain: Prior Treatment - Systemic Regimens, Brain: Prior Treatment - CNS RT, Brain: Prior Treatment - CNS Surgery
Metastatic Brain Cancer - On-Study Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EF3A8ACE-5457-4C56-E034-0003BA3F9857

On-Study - Primary Brain Cancer - On-Study Form Recurrent Treatment - 2293986v3.0 - Primary Brain Cancer - On-Study Form Recurrent Treatment

- 09/01/2015 - 1 Formulaire, 9 Groupes Item, 62 Eléments de données, 1 Langue
Groupes Item: CRF Header, Brain: Form Administration, Brain: Recurrent Disease Description, Brain: Neurologic Function, Brain: Concomitant Medications, Brain: Prior Health History, Brain: Prior Treatment, Brain: Prior Treatment - Systemic Regimens, Comments
Primary Brain Cancer - On-Study Form Recurrent Treatment Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E51DA7FB-264B-3B94-E034-0003BA3F9857

On-Study - Primary Brain Cancer - On-Study Form Newly Diagnosed Patients - 2293729v3.0 - Primary Brain Cancer - On-Study Form Newly Diagnosed Patients

- 09/01/2015 - 1 Formulaire, 7 Groupes Item, 45 Eléments de données, 1 Langue
Groupes Item: CRF Header, Brain: Form Administration, Brain: Disease Description, Brain: Neurologic Function, Brain: Prior Health History, Brain: Concomitant Medications, Brain: Prior Surgical Treatment for Primary Site
Primary Brain Cancer - On-Study Form Newly Diagnosed Patients Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E51E77B9-7E48-3A03-E034-0003BA3F9857

Fondaparinux in Addition to Intermittent Pneumatic Compression in Abdominal Surgery Patients at VTE Risk - NCT00038961 - Follow-Up

- 16/10/2019 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 1 Langue
Groupes Item: Administrative documentation, Follow-Up or Last Contact
Study ID: 103414 Clinical Study ID: 103414 Study Title: A Multicenter, Randomized, Double-blind, Parallel Group Trial to Demonstrate the Efficacy of Fondaparinux Sodium in Association With Intermittent Pneumatic Compression (IPC) Versus IPC Used Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal surgery Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00038961 https://clinicaltrials.gov/ct2/show/NCT00038961 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Fondaparinux Sodium Trade Name: Fondaparinux Sodium Study Indication: Thrombosis This phase III placebo-controlled trial studies the efficacy and safety of Fondaparinux as an additional prevention measure of venous thromboembolic events (VTE) in patients above the age of 40 with intermediate or high VTE risk undergoing abdominal surgery. The study consists of a Screening Visit (Visit 0), the baseline visit on Day 1, the day of the surgery (Visit 1), the treatment period (denoted in its entirety as Visit 2) consisting of administration of Fondaparinux (2.5mg subcutaneously once daily) or placebo starting on Day 1 and continuing at least up to Day 5, possibly up to Day 9, in parallel to intermittent pneumatic compression and possibly elastic stockings, followed by a mandatory bilateral venography no longer than 24 hours after study drug cessation, and finally a Follow-up Visit (Visit 3) on Day 30 +/- 2. This form is to be filled in at the Follow-up Visit (Visit 3) on Day 30 +/- 2 or can be used for the last contact information.

NSABP PROTOCOL C-09: ON-STUDY FORM NCT00268463

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 16 Eléments de données, 1 Langue
Groupes Item: Header, Primary Colorectal Tumor
NSABP PROTOCOL C-09: ON-STUDY FORM NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7D974C-8A71-3E64-E034-0003BA3F9857

Brain and Central Nervous System Tumors NCT00884741 On-Study - RTOG 0825: QOL M.D. Anderson Symptom Inventory - 2800871v1.0 - RTOG 0825: QOL M.D. Anderson Symptom Inventory

- 20/09/2021 - 1 Formulaire, 4 Groupes Item, 50 Eléments de données, 1 Langue
Groupes Item: Header Module, QOL Cover Sheet, Part I. M.D. Anderson Symptom Inventory (MDASI-BT), Part II
RTOG 0825: QOL M.D. Anderson Symptom Inventory Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5BABD9A9-3DF8-0152-E044-0003BA3F9857

HIV Cancer Sunitinib NCT00890747 AMC-061 - Protocol Deviation Form (DEV)

- 12/06/2017 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Header Module, Protocol Deviation
AMC-061 Protocol Deviation Form (DEV) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

HIV Cancer Sunitinib NCT00890747 AMC-061 - Missed Visit Form (F35)

- 12/06/2017 - 1 Formulaire, 2 Groupes Item, 6 Eléments de données, 1 Langue
Groupes Item: Header Module, Missed Visit Information
AMC-061 Missed Visit Form (F35) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

RTOG 0825 Phase III GBM Initial Evaluation Form (I1)

- 04/08/2015 - 1 Formulaire, 10 Groupes Item, 86 Eléments de données, 1 Langue
Groupes Item: Header Module, General Information, DISEASE INFORMATION, PRE-STUDY SCANS, PRE-STUDY SCANS1, LOCATION OF PRIMARY, Baseline Lab Values, Systemic Treatment, SEVERE ACTIVE COMORBIDITY, Footer Module
RTOG 0825 Phase III GBM Initial Evaluation Form (I1) Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AE2A23C-8AD1-6A8B-E044-0003BA3F9857

RTOG 0834: Medical Outcome Scale: Cognitive NCT00626990

- 08/07/2015 - 1 Formulaire, 3 Groupes Item, 29 Eléments de données, 1 Langue
Groupes Item: RTOG clinical trial administrative data, Various questionnaire related information, Cognition Quality of Life
RTOG 0834/EORTC 26053_22054/NCIC CTG CEC.1: Medical Outcome Scale: Cognitive NCT00626990 Radiation Therapy With or Without Temozolomide in Treating Patients With Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AF816A5-3103-0942-E044-0003BA3F9857

ADVL0212: On Study Worksheet [reload] NCT00053963

- 05/07/2015 - 1 Formulaire, 7 Groupes Item, 42 Eléments de données, 1 Langue
Groupes Item: Header, Treatment related information, Diagnosis, Hemogram, Chemistries, Comments, CCRR MODULE
ADVL0212: On Study Worksheet [reload] NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B304C5F5-C7EC-0452-E034-0003BA12F5E7

ADVL0212: Pre-Existing Conditions At Time of Study Entry NCT00053963

- 05/07/2015 - 1 Formulaire, 4 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Header, Adverse event assessment, Comments, CCRR MODULE
ADVL0212: Pre-Existing Conditions At Time of Study Entry NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BB5F4F72-BF42-1043-E034-0003BA12F5E7

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial